Galveston, TX, United States of America

Mateusz Gierdalski

This inventor holds 1 USPTO granted patent. Top assignee: Slipstream Solutions, LLC.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mateusz Gierdalski. Retrieved from https://idiyas.com/inventor/mateusz-gierdalski-miuwu6p0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mateusz Gierdalski: Inventor of a Fluid-Stasis Treatment System.

Introduction

Mateusz Gierdalski is an inventor associated with Galveston, Texas, and Slipstream Solutions, LLC. His work includes an invention designed to help move static fluid toward natural drainage areas.

Latest Patents

Gierdalski is credited with 1 patent, titled “Systems and Methods for Treating Fluid Stasis.” The patent describes using an airstream to induce shear-thinning in static fluid and direct its movement toward one or more natural drainage areas. The system includes an airflow generator that supplies air to a nozzle, which is configured to direct the airstream onto a patient.

Career Highlights

A key highlight of Gierdalski’s inventive work is the development of an airflow-based approach to treating fluid stasis. The patent outlines a system intended to support the movement of static fluid through controlled airflow.

Collaborations

Gierdalski is associated with Slipstream Solutions, LLC. His coworker, Mark Hernandez, is also identified in the information provided.

Conclusion

Mateusz Gierdalski’s patented system applies directed airflow to address fluid stasis, reflecting his contribution to the development of a treatment-focused invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…